Iša, Pavel
Taboada, Blanca
García-López, Rodrigo
Boukadida, Celia
Ramírez-González, José Ernesto
Vázquez-Pérez, Joel Armando
Hernández-Terán, Alejandra
Romero-Espinoza, José Ángel
Muñoz-Medina, José Esteban
Grajales-Muñiz, Concepción
Rincón-Rubio, Alma
Matías-Florentino, Margarita
Sanchez-Flores, Alejandro
Mendieta-Condado, Edgar
Barrera-Badillo, Gisela
López, Susana
Hernández-Rivas, Lucía
López-Martínez, Irma
Ávila-Ríos, Santiago
Arias, Carlos F.
Article History
Received: 6 May 2022
Accepted: 6 October 2022
First Online: 19 October 2022
Declarations
:
: Samples were collected and processed as part of the national response to COVID-19 under the Mexican Official NOM-017-SSA2-2012 for epidemiological surveillance of Viral Respiratory Disease emitted and approved by the CONAVE (National Counsel of Epidemiology Surveillance) of the Ministry of Health of the Government of Mexico. Samples were collected at the “Instituto de Diagnóstico y Referencia Epidemiológicos” (InDRE) and “Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas” (INER), by guidance and regulations of declaration of Helsinki, as part of the early diagnostics scheme in public health laboratories and hospitals in Mexico City (Red Nacional de Laboratorios Estatales de Salud Pública, RNLSP; Instituto Nacional de Enfermedades Respiratorias, INER; and Instituto Mexicano del Seguro Social, IMSS). Based on Mexican Official NOM-017-SSA2-2012 Institutional Review Board (IRB), approval is not required. Nor informed consent from patients was required. All samples were anonymized before use.
: Not applicable.
: The authors declare that they have no competing interests.